Transaction DateRecipientSharesTypePriceValue
27th January 2021Susan H Alexander4,545Grant/award etc.$0.00
20th January 2021Anthony La Placa1,500Open or private sale$10.45$15,675.00
15th January 2021Anthony La Placa7,500Open or private sale$9.93$74,475.00
27th May 2020Matthew E. Monaghan2,803Grant/award etc.$62.43$174,991.29
20th May 2020C Martin Harris572Grant/award etc.$0.00
15th May 2020Darcie Karol1,305Payment by withholding$5.66$7,386.30
15th May 2020Kathleen P. Leneghan5,521Payment by withholding$5.66$31,248.86
15th May 2020Matthew E. Monaghan41,326Payment by withholding$5.66$233,905.16
15th May 2020Anthony La Placa2,512Payment by withholding$5.66$14,217.92
11th May 2020C Martin Harris1,946Grant/award etc.$0.00
Invacare Corporation
Invacare Corporation logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.

Invacare Corp. focuses on medical device solutions for congenital, acquired, and degenerative ailments. It operates through the following segments: Europe, NA/HME, Institutional Products Group, and Asia Pacific. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

Ticker: IVC
Sector: Healthcare
Industry: Medical Devices
SEC Central Index Key (CIK): 742112
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $104 M (30%)
Inventory, Net: $148 M (0%)
Other Assets, Current: $45 M (0%)
Assets, Current: $392 M (10%)
Property, Plant and Equipment, Net: $48 M (0%)
Other Assets, Noncurrent: $4 M (0%)
Assets: $886 M (3%)
Long-term Debt, Current Maturities: $53 M (91224%)
Accounts Payable, Current: $106 M (19%)
Accrued Liabilities, Current: $109 M (0%)
Liabilities, Current: $278 M (27%)
Long-term Debt, Excluding Current Maturities: $204 M (-6%)
Other Liabilities, Noncurrent: $67 M (0%)
Retained Earnings (Accumulated Deficit): $71 M (-18%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $5 M (0%)
Treasury Stock, Value: $1 M (1%)
Treasury Stock, Shares: $42 Th (5%)
Stockholders' Equity (Parent): $302 M (0%)
Liabilities and Equity: $886 M (3%)
Gross Margin: $57 M (-52%)
Restructuring Charges: $2 M (0%)
Operating Income/Loss: $2 M (0%)
Provision for income taxes: $750 Th (-73%)
EPS (basic): $0.48 (0%)
EPS (diluted): $0.48 (0%)